Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001823 · ClinicalTrials.gov registry record
Evaluation for NCI Surgery Branch Clinical Research Protocols
A clinical trial of Lung Cancer and Colorectal Cancer, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 7,000
- Enrollment target
- 1
- Study location
NCT00001823 is a study of Lung Cancer and Colorectal Cancer that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 7,000 participants, above the 919-participant average among 409 other Lung Cancer trials with a reported enrollment target (662% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00001823, a study of Lung Cancer and Colorectal Cancer, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 7,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow patients to under screening and evaluation for participation in NC-SB Protocols. Eligibility: Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol. Design Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol. ...
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,000 participants |
| Start Date | 1999-07-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001823
The ClinicalTrials.gov registry entry for NCT00001823 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 7,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 919-participant average among 409 other Lung Cancer trials with a reported enrollment target (662% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00001823 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001823 about?
NCT00001823 is a clinical study titled "Evaluation for NCI Surgery Branch Clinical Research Protocols". Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This st...
What is the current status of trial NCT00001823?
This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 1999-07-11.
What conditions does trial NCT00001823 study?
This clinical trial studies the following conditions: Lung Cancer, Colorectal Cancer, Melanoma, Bladder Cancer, Synovial Cell Cancer.
Who is sponsoring clinical trial NCT00001823?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001823 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.